Hapten Sciences, Inc.
MEMPHIS, TN · Founded 2011 · CIK 0001526465 · Biotech · Private
Novel small-molecule therapeutics and drug candidates identified through proprietary screening and development platform
haptensciences.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.7M
- 9 Form D · Aug 2021
- 62 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 1 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2010201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,650,000 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $225,000 | |
| Private capital raised | Form D · SEC | $1,200,000 | |
| Private capital raised | Form D · SEC | $108,200 | |
| Private capital raised | Form D · SEC | $885,980 | |
| Private capital raised | Form D · SEC | $3,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1814 | Rectify | — | — |
| 1815 | Phylo | — | — |
| 1816 | Pupil Bio, Inc. | — | $500K |
| 1817 | Hapten Sciences, Inc. | — | $2.7M |
| 1818 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | — | — |
| 1819 | KYRON, INC. | — | $3.0M |
| 1820 | MBQ PHARMA INC. | — | $4.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Stephen BandakDirector
- Raymond HageDirector · Executive Officer · Promoter
- Gary ProstermanDirector · Executive Officer · Promoter
- Gary StevensonDirector
- Joseph ZakrzewskiDirector
Patents
- Patches Comprising Urushiol, Test Panels Comprising The Same, And Methods Of Using The Sameapplication
- Patches Comprising Urushiol, Test Panels Comprising The Same, And Methods Of Using The Samegranted
- Patches Comprising Urushiol, Test Panels Comprising The Same, And Methods Of Using The Sameapplication
- Patches Comprising Urushiol, Test Panels Comprising The Same, And Methods Of Using The Sameapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.